文献速递重症综合管理与镇静镇痛

成人ECMO支持患者医院感染的发生率、危险因素与结局:系统评价与Meta分析

Incidence, risk factors and outcomes of nosocomial infection in adult patients supported by extracorporeal membrane oxygenation: a systematic review and meta-analysis.
PubMed 文献 · Crit Care · 2024-05-10
一句话结论成人ECMO患者医院感染合并发生率26%(95%CI 14-38%),感染患者ECMO生存与总生存分别降低16%和20%,院内死亡风险增加37%。

该系统评价与Meta分析检索PubMed、Scopus、Web of Science和ProQuest至2022年,纳入30项研究、4733例接受ECMO支持的成人患者。18项研究3424例患者医院感染合并发生率为26%(95%CI 14-38%),每1000个ECMO日发生1249例ECMO相关医院感染;呼吸机相关性肺炎和血流感染是最常见感染来源。感染患者ECMO生存率(RR 0.84,95%CI 0.74-0.96,P=0.01)和总生存率(RR 0.80,95%CI 0.71-0.90,P<0.001)低于非感染患者,院内死亡风险增加37%,ECMO持续时间与ECMO相关医院感染呈显著正相关。

要点

  • 18项研究3424例成人ECMO患者医院感染合并发生率为26%(95%CI 14-38%)。
  • 30项研究4733例患者中,每1000个ECMO日观察到1249例ECMO相关医院感染。
  • 呼吸机相关性肺炎与血流感染是最常见的医院感染来源。
  • 感染患者ECMO生存率低于非感染患者(RR 0.84,95%CI 0.74-0.96,P=0.01)。
  • 感染患者总生存率低于非感染患者(RR 0.80,95%CI 0.71-0.90,P<0.001),院内死亡风险增加37%。

适用人群与场景

  • 接受体外膜氧合(ECMO)支持的成人患者。

研究设计与关键结果

  • 研究类型为系统评价与Meta分析,检索PubMed、Scopus、Web of Science和ProQuest数据库至2022年,纳入30项研究、4733例接受ECMO支持的成人患者。
  • 30项研究4733例患者中观察到每1000个ECMO日1249例ECMO相关医院感染。
  • 18项研究3424例患者医院感染合并发生率为26%(95%CI 14-38%)。
  • 呼吸机相关性肺炎和血流感染是最常见的医院感染来源。
  • 感染患者ECMO生存率低于非感染患者,RR 0.84(95%CI 0.74-0.96,P=0.01)。
  • 感染患者总生存率低于非感染患者,RR 0.80(95%CI 0.71-0.90,P<0.001)。
  • 感染患者院内死亡风险较非感染患者增加37%。
  • ECMO持续时间与ECMO相关医院感染呈显著正相关。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,ECMO持续时间与ECMO相关医院感染呈显著正相关,感染患者ECMO生存和总生存分别降低16%和20%,院内死亡风险增加37%。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: An increasing number of patients requires extracorporeal membrane oxygenation (ECMO) for life support. This supportive modality is associated with nosocomial infections (NIs). This systematic review and meta-analysis aim to assess the incidence and risk factors of NIs in adult.

METHODS: We searched PubMed, Scopus, Web of Science, and ProQuest databases up to 2022. The primary endpoint was incidence of NI. Secondary endpoints included time to infection, source of infection, ECMO duration, Intensive care and hospital length of stay (LOS), ECMO survival and overall survival. Incidence of NI was reported as pooled proportions and 95% confidence intervals (CIs), while dichotomous outcomes were presented as risk ratios (RR) as the effective index and 95% CIs using a random-effects model.

RESULTS: Among the 4,733 adult patients who received ECMO support in the 30 included studies, 1,249 ECMO-related NIs per 1000 ECMO-days was observed. The pooled incidence of NIs across 18 studies involving 3424 patients was 26% (95% CI 14-38%).Ventilator-associated pneumonia (VAP) and bloodstream infections (BSI) were the most common NI sources. Infected patients had lower ECMO survival and overall survival rates compared to non-infected patients, with risk ratio values of 0.84 (95% CI 0.74-0.96, P = 0.01) and 0.80 (95% CI 0.71-0.90, P < 0.001), respectively.

CONCLUSION: Results showed that 16% and 20% lower of ECMO survival and overall survival in patients with NI than patients without NI, respectively. However, NI increased the risk of in-hospital mortality by 37% in infected patients compared with non-infected patients. In addition, this study identified the significant positive correlation between ECMO duration and ECMO-related NI.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Ait Hssain A, Vahedian-Azimi A, Ibrahim AS, et al. Incidence, risk factors and outcomes of nosocomial infection in adult patients supported by extracorporeal membrane oxygenation: a systematic review and meta-analysis. Crit Care. 2024. PMID: 38730424. doi:10.1186/s13054-024-04946-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。